durvalumab

durvalumab is a topic covered in the Davis's Drug Guide.

To view the entire topic, please or purchase a subscription.

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

Pediatrics Central

-- The first section of this topic is shown below --

General

Pronunciation:
dur-val-ue-mab

Trade Name(s)

  • Imfinzi

Ther. Class.
antineoplastics

Pharm. Class.
monoclonal antibodies
programmed death ligand 1 (PD-L1) inhibitors

-- To view the remaining sections of this topic, please or purchase a subscription --